Hinova Pharmaceuticals (SHSE:688302) Accounts Payable & Accrued Expense : ¥121.36 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals Accounts Payable & Accrued Expense?

Hinova Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥146.46 Mil) to Dec. 2024 (¥143.73 Mil) and declined from Dec. 2024 (¥143.73 Mil) to Mar. 2025 (¥121.36 Mil).

Hinova Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2022 (¥105.83 Mil) to Dec. 2023 (¥103.08 Mil) but then increased from Dec. 2023 (¥103.08 Mil) to Dec. 2024 (¥143.73 Mil).

Hinova Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hinova Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hinova Pharmaceuticals Accounts Payable & Accrued Expense Chart

Hinova Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

62.99

97.60

105.83

103.08

143.73

Hinova Pharmaceuticals Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															86.82	138.13	146.46	143.73	121.36

Hinova Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hinova Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041

Website

http://www.hinovapharma.com

Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals Headlines

No Headlines